Clinical trials are a critical phase in the development of any new medicine. They are vital to determining the impact the treatment may have on patients. Since the beginning of the COVID-19 pandemic, clinical researchers throughout Southeast Asia have been working rapidly to test investigational medicines and identify possible vaccine candidates that may treat patients and prevent further spread of the virus.
Health systems in many low- and middle-income countries across Asia, the Middle East, Africa and Latin America are strained as they cope with the COVID-19 pandemic. Many nations lack the medical staff, equipment and capacities necessary to mitigate the crisis. While governments and corporations are partnering to strengthen health systems, multinational organizations are also stepping in with financial support.
Strong intellectual property (IP) protection and enforcement is critical to helping countries attract foreign investment, promote economic growth, provide greater access to medicines and improve patient outcomes. The biennial “Report on the Protection and Enforcement of Intellectual Property Rights in Third Countries” cites Malaysia, Indonesia and Thailand as priority countries that will need to strengthen their IP regulations to stay globally competitive.
Explore the Countries
Indonesia has achieved significant health milestones, but rising rates of NCDs bring new challenges.
Malaysia can attract new foreign investment and improve health outcomes by better protecting innovation and reducing bureaucratic delays.
Increasing public-private partnerships in the Philippines will bring health care innovation to a rapidly growing population
Health care is poised to become a major economic driver in Thailand in the coming years.
The success of Singapore’s health care system can be attributed to strong policies and an integrated health system.